Core Viewpoint - New Nuo Wei's stock price has shown volatility, with a year-to-date decline of 1.91% and a significant drop of 8.98% over the past five trading days, while experiencing an increase of 11.86% over the last 60 days [2] Group 1: Stock Performance - On February 6, New Nuo Wei's stock rose by 2.05%, reaching a price of 35.38 yuan per share, with a trading volume of 1.05 billion yuan and a market capitalization of 49.694 billion yuan [1] - The stock has appeared on the "Dragon and Tiger List" once this year, with a net buy of -126 million yuan on January 30, where total purchases amounted to 314 million yuan, accounting for 21.64% of total trading volume, and total sales reached 440 million yuan, making up 30.30% of total trading volume [2] Group 2: Financial Performance - For the period from January to September 2025, New Nuo Wei reported a revenue of 1.593 billion yuan, reflecting a year-on-year growth of 7.71%, while the net profit attributable to shareholders was -24.049 million yuan, a decrease of 117.26% year-on-year [2] Group 3: Shareholder Information - As of January 30, 2025, New Nuo Wei had 17,500 shareholders, an increase of 0.28% from the previous period, with an average of 80,349 circulating shares per shareholder, a decrease of 0.27% [2] - The company has distributed a total of 651 million yuan in dividends since its A-share listing, with 500 million yuan distributed over the past three years [3] - The top ten circulating shareholders include Hong Kong Central Clearing Limited as the second-largest shareholder with 17.7822 million shares, a decrease of 3.2169 million shares from the previous period [3]

Core Viewpoint - Xianle Health's stock has experienced a decline of 11.33% year-to-date, with significant drops in recent trading periods, indicating potential concerns regarding its market performance and investor sentiment [1]. Financial Performance - For the period from January to September 2025, Xianle Health reported a revenue of 3.291 billion yuan, reflecting a year-on-year growth of 7.96% [2]. - The net profit attributable to shareholders for the same period was 260 million yuan, showing an increase of 8.53% compared to the previous year [2]. Stock and Market Activity - As of February 2, Xianle Health's stock price was 22.93 yuan per share, with a market capitalization of 7.054 billion yuan [1]. - The stock has seen a trading volume of 43.247 million yuan, with a turnover rate of 0.73% [1]. - The company experienced a net outflow of 1.7844 million yuan in principal funds, with significant selling pressure observed [1]. Shareholder Information - As of September 30, 2025, Xianle Health had 11,800 shareholders, a decrease of 2.97% from the previous period [2]. - The average number of circulating shares per shareholder increased by 3.02% to 21,811 shares [2]. Dividend Distribution - Since its A-share listing, Xianle Health has distributed a total of 583 million yuan in dividends, with 415 million yuan distributed over the last three years [3]. Institutional Holdings - Notable new institutional shareholders include Dongfanghong Jingdong Big Data Mixed A and Dongfanghong New Power Mixed A, both entering the top ten circulating shareholders [3].